|View printer-friendly version|
|ERYTECH Pharma: Information related to total number of voting rights and shares composing the share capital –May 31st, 2017|
Article 223-16 of general regulation of French Autorité des Marchés Financiers
Listing market: Euronext Paris from
ISIN Code : FR0011471135
website : www.erytech.com
(1) Gross voting rights number (or « theoretical » voting rights) is used as a calculus base for the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares
(3) The number of shares and voting rights raised following the issuance of 3 000 000 new shares (cf. Note d’opération Visa n°17-161 available on the Company’s website)
(4) The number of shares increased due to issuance of shares consequently to warrants exercises which a Board of Director will take notice of in the future.